Porton is excited to announce construction of a new, state-of-the-art Crystallization and Drug Product facility in Cranbury, NJ. The new building is projected to open in Q4 of 2022. This facility will be cGMP capable for Drug Product supplies, and will expand our ability to offer integrated Drug Substance (DS) and Drug Product (DP) R&D …
New State-of-the-Art Crystallization and Drug Product Facility Read More »
J-Star Research’s subject matter experts are presenting at 2021 AAPS PharmSci360, in Philadelphia, PA, on October 17-20. Our synergistically integrated DS-DP team will discuss the enabling technologies and unique capabilities at J-Star for debottlenecking drug substance (DS) and drug product (DP) developments. We will present through three technical posters and J-Star Booth #1111. Three technical …
We are proud to announce that Porton’s Chairman and CEO, Niafeng (Oliver) Ju (EMBA), and San Kiang (Ph.D.), CTO of Porton/J-Star Research, will be Keynote Speaker and CMC Speaker, respectively, at this year’s Sino-American Professionals Association (SAPA) Annual Conference on October 2. Oliver will present “Contract Organizations: from Outsourcing Partner to Infrastructure in the Industry …